Bevacizumab-associated intestinal perforation and perioperative complications in patients receiving bevacizumab.
Toshiaki YoshimotoKozo YoshikawaJun HigashijimaTomohiko MiyataniTakuya TokunagaMasaaki NishiChie TakasuHideya KashiharaYukako TakeharaMitsuo ShimadaPublished in: Annals of gastroenterological surgery (2020)
The surgical indications should be considered carefully in patients with gastrointestinal perforation secondary to bevacizumab administration. Meanwhile, after appropriate cessation time, scheduled surgery following bevacizumab administration is feasible.